Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hadar Duskin-Bitan

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Clinical Rheumatology|February 14, 2014
The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohortHadar Duskin-Bitan, Eytan Cohen, Elad Goldberg, et al.
Diabetes/Metabolism Research and Reviews|May 19, 2018
Outcomes of hyperglycemia in patients with and without diabetes hospitalized for infectious diseasesAmit Akirov, Talia Diker-Cohen, Hiba Masri-Iraqi, et al.
Clinical Endocrinology|January 5, 2023
Natural history of nonfunctioning pituitary macroadenomas followed without intervention: A retrospective cohort studyIrit Ayalon-Dangur, Eyal Robenshtok, Hadar Duskin-Bitan, et al.
Clinical Endocrinology|June 23, 2021
Long-term response to cabergoline and multi-modal treatment in men with macroprolactinoma: Does size really matter?Yaron Rudman, Hadar Duskin-Bitan, Yossi Manisterski, et al.
Andrology|March 10, 2023
Hemoglobin decline as a signal for hyperprolactinemia onset prior to prolactinoma diagnosis in hypogonadal menYaron Rudman, Hadar Duskin-Bitan, Ilan Richter, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2018
Impact of Minimal Extra-Thyroid Extension in Differentiated Thyroid Cancer: Systematic Review and Meta-analysisTalia Diker-Cohen, Dania Hirsch, Ilan Shimon, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 2, 2018
DISEASE PRESENTATION AND REMISSION RATE IN GRAVES DISEASE TREATED WITH ANTITHYROID DRUGS: IS GENDER REALLY A FACTOR?Talia Diker-Cohen, Hadar Duskin-Bitan, Ilan Shimon, et al.
Trauma Surgery & Acute Care Open|October 25, 2021
Polymicrobial and monomicrobial necrotizing soft tissue infections: comparison of clinical, laboratory, radiological, and pathological hallmarks and prognosis. A retrospective analysisEviatar Naamany, Shachaf Shiber, Hadar Duskin-Bitan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 11, 2017
Second Radioiodine Treatment: Limited Benefit for Differentiated Thyroid Cancer With Locoregional Persistent DiseaseDania Hirsch, Alexander Gorshtein, Eyal Robenshtok, et al.
Thyroid : Official Journal of the American Thyroid Association|May 16, 2019
Bone-Marrow Suppression in Elderly Patients Following Empiric Radioiodine Therapy: Real-Life DataHadar Duskin-Bitan, Anat Leibner, Oren Amitai, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Clinical Rheumatology|February 14, 2014
The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohortHadar Duskin-Bitan, Eytan Cohen, Elad Goldberg, et al.
Diabetes/Metabolism Research and Reviews|May 19, 2018
Outcomes of hyperglycemia in patients with and without diabetes hospitalized for infectious diseasesAmit Akirov, Talia Diker-Cohen, Hiba Masri-Iraqi, et al.
Clinical Endocrinology|January 5, 2023
Natural history of nonfunctioning pituitary macroadenomas followed without intervention: A retrospective cohort studyIrit Ayalon-Dangur, Eyal Robenshtok, Hadar Duskin-Bitan, et al.
Clinical Endocrinology|June 23, 2021
Long-term response to cabergoline and multi-modal treatment in men with macroprolactinoma: Does size really matter?Yaron Rudman, Hadar Duskin-Bitan, Yossi Manisterski, et al.
Andrology|March 10, 2023
Hemoglobin decline as a signal for hyperprolactinemia onset prior to prolactinoma diagnosis in hypogonadal menYaron Rudman, Hadar Duskin-Bitan, Ilan Richter, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2018
Impact of Minimal Extra-Thyroid Extension in Differentiated Thyroid Cancer: Systematic Review and Meta-analysisTalia Diker-Cohen, Dania Hirsch, Ilan Shimon, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 2, 2018
DISEASE PRESENTATION AND REMISSION RATE IN GRAVES DISEASE TREATED WITH ANTITHYROID DRUGS: IS GENDER REALLY A FACTOR?Talia Diker-Cohen, Hadar Duskin-Bitan, Ilan Shimon, et al.
Trauma Surgery & Acute Care Open|October 25, 2021
Polymicrobial and monomicrobial necrotizing soft tissue infections: comparison of clinical, laboratory, radiological, and pathological hallmarks and prognosis. A retrospective analysisEviatar Naamany, Shachaf Shiber, Hadar Duskin-Bitan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 11, 2017
Second Radioiodine Treatment: Limited Benefit for Differentiated Thyroid Cancer With Locoregional Persistent DiseaseDania Hirsch, Alexander Gorshtein, Eyal Robenshtok, et al.
Thyroid : Official Journal of the American Thyroid Association|May 16, 2019
Bone-Marrow Suppression in Elderly Patients Following Empiric Radioiodine Therapy: Real-Life DataHadar Duskin-Bitan, Anat Leibner, Oren Amitai, et al.
Pageof 4